Você esta aqui:Home > Therapeutics (antigo) > A Homelie Herbe: Medicinal Cannabis in Early England

J Cannabis Ther 2002(2):71-79

History

A Homelie Herbe: Medicinal Cannabis in Early England

Author
V. Crawford

Abstract
Cannabis is often regarded as a substance alien to British culture until the 1960s, at which supposed point of introduction it functioned as a marker of subversion. In fact cannabis was used as a medicinal herb by the Anglo-Saxons, and highly valued during the Tudor and Stuart periods. It remained in the British Materia medica through the 18th and 19th centuries, being well regarded by orthodox doctors. However, the type of cannabis grown in England was probably less rich in psychotropic cannabinoids than plants grown in the East.



Keywords
Anglo-Saxon herbalism, English Renaissance herbalism, cannabis, medicinal marijuana, history of medicine

PDF do texto completo ]

Free Online Events 2020

You can find all information here.

The IACM is holding a free webinar series and a free anniversary online meeting from October to November 2020

All webinars will be held in English with subtitles in German, French, Spanish, and Portuguese. All webinars will be available online until March 2021

The anniversary online meeting to celebrate the IACM's 20th anniversary and to honour the 90th birthday of Raphael Mechoulam will be a live session only on the 5th November 2020.

The speakers in the webinar series are Donald I. Abrams, Bonni Goldstein, Franjo Grotenhermen, Manuel Guzmán, Raphael Mechoulam, Kirsten Müller-Vahl, Roger Pertwee, Daniele Piomelli, and Ethan Russo.

You can find all information here.

Conferência 2021

A 12ª Conferência da IACM sobre Canabinoides em Medicina será realizada em Basileia, Suíça, de 14 a 16 de Outubro de 2021.

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.